Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA)

53 filings reported holding CNTA - Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share as of Q4 2021.
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 71.9M shares of 147M outstanding shares and own 48.78% of the company stock.
Largest 10 shareholders include Medicxi Ventures Management (Jersey) Ltd (18.1M shares), Index Venture Life Associates VI Ltd (9.96M shares), GENERAL ATLANTIC, L.P. (9.68M shares), JANUS HENDERSON GROUP PLC (5.74M shares), Vida Ventures Advisors, LLC (3.93M shares), RA CAPITAL MANAGEMENT, L.P. (3.58M shares), Cormorant Asset Management, LP (2.49M shares), OUP Management Co., LLC (2.34M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.08M shares), and Samsara BioCapital, LLC (1.46M shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.